Updated cervical cancer screening guidance from the American College of Obstetricians and Gynecologists endorsed at-home ...

Researchers at the University of Colorado Anschutz may have identified why many cancer patients say food suddenly tastes ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...

The stiffness of tumor tissue plays a role in how cancer spreads. Furthermore, stiff tumor tissue leaves traces in the ...

CatalYm today announced that the first patient has been dosed in the Phase 2/3 VINCIT trial (Visugromab IN Cachexia ...

Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Invenra, Inc., a biotechnology company pioneering multispecific antibody therapeutics, is requesting cancer patient and survivor artwork, which will be featured in an innovative project linking ...

A new study suggests that a common pesticide, picloram, may contribute to growing rates of early onset colorectal cancer, asides from known risk factors such as smoking and diet.

Pancreatic cancer has stymied treatment advances for decades. Data from new clinical trials shows promise.